ClinicalTrials.Veeva

Menu

Damage and Renal Clearance of Glycocalyx in Cardiac Surgery (GlycoCarSur)

M

Miguel Ayala León

Status

Completed

Conditions

Cardio-Renal Syndrome
Glycocalyx

Study type

Observational

Funder types

Other
NETWORK

Identifiers

NCT04332952
Cardiologia-002

Details and patient eligibility

About

The glycocalyx is a component of the vascular endothelium that currently plays a relevant role in the modified Starling theory.

The manipulation of the heart during cardiac surgery stimulates the release of the natriuretic atrial peptide, which causes endothelial wear in patients undergoing extracorporeal circulation. Dilation of the atrium produces natriuretic atrial peptide, which reduces plasma volume by increasing renal excretion and vascular permeability. The atrial peptide degrades the surface of the coronary endothelium, causing loss of the side cam protein nucleus. This study investigates the relationship between clamping time in cardiac surgery and the clearance of endothelial inflammation markers.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years of age
  • Patients who underwent cardiac surgery for a single valve change or replacement

Exclusion criteria

  • Stage 3 renal failure patients
  • Patients with a previous diagnosis of hematological malignancy
  • Patients undergoing pulmonary valve change surgery.
  • Patients undergoing Bentall and Bono surgery.
  • Patients Undergoing Coronary Artery Bypass Surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems